leadf
logo-loader
viewKhiron Life Sciences Corp.

Khiron Life Sciences continues to see great potential for growth in Latin America

Khiron Life Sciences (CVE:KHRN) President Chris Naprawa joined Steve Darling from Proactive Investors Vancouver to talk about the cannabis company that operates in Latin America. Naprawa talking about the success they have had, how Brazil could be quite lucrative next step for the company.

Naprawa also told Proactive about a joint venture they have done with Dixie Brands and how that partnership really benefits both companies in the future. 

Quick facts: Khiron Life Sciences Corp.

Price: 0.2965 USD

OTCQX:KHRNF
Market: OTCQX
Market Cap: $44.62 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Mountain Valley MD gets approval for COVID-19 clearance trial in Level 4 Bio...

Mountain Valley MD (CSE: MVMD) CEO Dennis Hancock and Director of Life Sciences Mike Farber joined Steve Darling with news the company will be conducting a Bio-Safety Level 4 lab study of COVID-19 viral clearance to prove out the Company’s solubilized Ivermectin technology versus commercially...

4 hours, 17 minutes ago

2 min read